| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
3,032 |
2,528 |
$0.00 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
422 |
222 |
$0.00 |
| 80061 |
Lipid panel |
2,927 |
2,903 |
$0.00 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
140 |
139 |
$0.00 |
| 3078F |
|
1,092 |
1,011 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
295 |
294 |
$0.00 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
268 |
268 |
$0.00 |
| 82540 |
|
692 |
684 |
$0.00 |
| 84450 |
|
71 |
71 |
$0.00 |
| 86703 |
|
1,038 |
1,033 |
$0.00 |
| 84439 |
|
37 |
37 |
$0.00 |
| 99442 |
|
326 |
321 |
$0.00 |
| 82274 |
|
479 |
479 |
$0.00 |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
16 |
16 |
$0.00 |
| 77062 |
|
132 |
132 |
$0.00 |
| 81003 |
|
76 |
73 |
$0.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
216 |
185 |
$0.00 |
| 3051F |
|
99 |
98 |
$0.00 |
| 3077F |
|
193 |
183 |
$0.00 |
| 84460 |
|
39 |
39 |
$0.00 |
| 86705 |
|
26 |
26 |
$0.00 |
| 82570 |
|
80 |
74 |
$0.00 |
| 3046F |
|
36 |
36 |
$0.00 |
| 83540 |
|
178 |
178 |
$0.00 |
| 91300 |
|
12 |
12 |
$0.00 |
| 80076 |
|
59 |
59 |
$0.00 |
| 99215 |
Prolong outpt/office vis |
12 |
12 |
$0.00 |
| 85610 |
|
44 |
41 |
$0.00 |
| 80074 |
|
29 |
29 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
12 |
12 |
$0.00 |
| 86480 |
|
30 |
30 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
63 |
60 |
$0.00 |
| 86900 |
|
12 |
12 |
$0.00 |
| 97161 |
|
12 |
12 |
$0.00 |
| 84100 |
|
13 |
12 |
$0.00 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
12 |
12 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,646 |
2,425 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
751 |
745 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
3,131 |
2,896 |
$0.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
115 |
107 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
295 |
294 |
$0.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,292 |
1,234 |
$0.00 |
| 99441 |
|
12 |
12 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
932 |
927 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
6,735 |
5,935 |
$0.00 |
| 1111F |
|
392 |
374 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,363 |
3,340 |
$0.00 |
| 82728 |
|
150 |
150 |
$0.00 |
| 82043 |
|
692 |
684 |
$0.00 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,113 |
1,989 |
$0.00 |
| 85652 |
|
126 |
123 |
$0.00 |
| 85027 |
|
664 |
650 |
$0.00 |
| 83735 |
|
227 |
172 |
$0.00 |
| 82607 |
|
189 |
189 |
$0.00 |
| 86780 |
|
433 |
429 |
$0.00 |
| 87340 |
|
100 |
100 |
$0.00 |
| 3079F |
|
267 |
258 |
$0.00 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
146 |
146 |
$0.00 |
| 97010 |
|
130 |
82 |
$0.00 |
| 3080F |
|
41 |
40 |
$0.00 |
| 83550 |
|
159 |
159 |
$0.00 |
| 99443 |
|
184 |
180 |
$0.00 |
| 86141 |
|
113 |
110 |
$0.00 |
| 3044F |
|
619 |
615 |
$0.00 |
| 3074F |
|
1,004 |
934 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
594 |
587 |
$0.00 |
| 3075F |
|
269 |
263 |
$0.00 |
| 90656 |
|
12 |
12 |
$0.00 |
| 81001 |
|
221 |
214 |
$0.00 |
| 87522 |
Neg quan hep c or qual rna |
592 |
587 |
$0.00 |
| 86901 |
|
12 |
12 |
$0.00 |
| 86706 |
|
41 |
41 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
63 |
60 |
$0.00 |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
33 |
24 |
$0.00 |
| 76830 |
Ultrasound, transvaginal |
16 |
16 |
$0.00 |
| 82746 |
|
14 |
14 |
$0.00 |
| 86592 |
|
40 |
40 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
53 |
36 |
$0.00 |